Viral Infection and Adenovirus Disease
Symbio Pharmaceuticals Ltd. is involved in clinical research focused on adenovirus viremia, with interest in the treatment of adenovirus infection in both children and adults.
- Adenovirus viremia
- Adenovirus infection
- Post-transplant viral disease
The sponsor’s research activity is centered on management of viral complications in medically vulnerable patients.
Transplant Medicine and Haematopoietic Stem Cell Transplantation
The company’s clinical interest extends to infectious complications occurring after allogeneic haematopoietic stem cell transplantation, particularly in patients recovering from stem cell transplant procedures.
- Allo-HCT
- Stem cell transplant recipients
- Post-transplant infection
This area reflects a therapeutic focus on transplant-associated infectious risk and the care of immunocompromised populations.
Antiviral Therapy
Symbio Pharmaceuticals Ltd. is engaged in research on antiviral treatment options for adenoviral disease, with attention to agents used for controlling systemic viral infection.
- Brincidofovir
- Cidofovir
- Antiviral efficacy
The sponsor’s therapeutic interest lies in clinical management of difficult-to-treat viral infections in transplant settings.
